Rapidly narrow the field of potential drug candidates and new applications for existing compounds, using the latest AI software on a dedicated HPC cloud-based platform.
AI-enabled frameworks and tools designed for drug discovery, such as NVIDIA BioNeMo, combined with HPC running on AWS and the easy-to-use Rescale platform, enable researchers to identify the right drug candidates for preclinical and clinical trials faster.
This eBook addresses common industry challenges and how AI-technology accelerates drug discovery pipelines. Download a copy of the eBook to learn more.